financetom
Business
financetom
/
Business
/
New Auto Tariffs Could Hike Car Prices by up to $10,000, Wedbush Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
New Auto Tariffs Could Hike Car Prices by up to $10,000, Wedbush Says
Mar 27, 2025 3:56 AM

06:41 AM EDT, 03/27/2025 (MT Newswires) -- Car prices in the US are expected to increase by $5,000 to $10,000 on average amid the Trump administration's latest auto tariffs, Wedbush Securities said Wednesday.

President Donald Trump has announced new tariffs on foreign-made cars, including a 25% tariff on all cars made outside the US, the brokerage said in a note to clients.

"In our view, these initial tariffs (if they hold in their current form) would be a hurricane-like headwind to foreign (and many US) automakers," Wedbush said. "We continue to believe this will be ultimately finished cars which is less onerous for [General Motors ( GM ) ] and Ford (F)."

Electric vehicle maker Tesla (TSLA) is likely to be "less exposed" to tariffs as its production and assembly is entirely in the US, according to the note.

GM shares were down 6.5% in recent premarket activity Thursday, while Ford fell 3%. Tesla was up 0.7%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Capricor Therapeutics, Nippon Shinyaku Sign Binding Term Sheet for Commercialization of Duchenne Muscular Dystrophy Treatment in Europe
Capricor Therapeutics, Nippon Shinyaku Sign Binding Term Sheet for Commercialization of Duchenne Muscular Dystrophy Treatment in Europe
Sep 17, 2024
10:31 AM EDT, 09/17/2024 (MT Newswires) -- Capricor Therapeutics ( CAPR ) said Tuesday it signed a binding term sheet with Japanese pharmaceutical firm Nippon Shinyaku to commercialize and distribute Capricor's Duchenne muscular dystrophy treatment deramiocel in Europe. Capricor said the potential deal that the term sheet covers is similar to the existing commercialization and distribution agreements with Nippon Shinyaku...
INmune Bio Says AD02 Trial for Alzheimer's Disease Reveals Strong Performance of EMACC Cognitive Measure
INmune Bio Says AD02 Trial for Alzheimer's Disease Reveals Strong Performance of EMACC Cognitive Measure
Sep 17, 2024
10:19 AM EDT, 09/17/2024 (MT Newswires) -- INmune Bio ( INMB ) said Tuesday that additional analysis from its AD02 phase 2 trial for Alzheimer's disease showed exceptional performance of the Early AD/MCI Alzheimer's Cognitive Composite, or EMACC, measure. The analysis revealed a highly significant correlation between baseline scores on EMACC and the Clinical Dementia Rating-Sum of Boxes, or CDR-SB,...
Intel Updates Viewed in 'Positive Light' But Not Sufficient to Overcome Challenges, Truist Says
Intel Updates Viewed in 'Positive Light' But Not Sufficient to Overcome Challenges, Truist Says
Sep 17, 2024
10:20 AM EDT, 09/17/2024 (MT Newswires) -- Intel's ( INTC ) recent business update announcements are viewed in a positive light but are not sufficient to overcome issues the company is facing, Truist Securities said in a note Tuesday. The highlights include Intel Foundry operating as an independent unit; the company receiving up to $3 billion in US government chip...
Uber to roll out 'verified' rider badge, trip recording features in US
Uber to roll out 'verified' rider badge, trip recording features in US
Sep 17, 2024
Sept 17 (Reuters) - Uber ( UBER ) is rolling out features that would allow its drivers to see verified badges on customer profiles and record trips on their smartphones instead of a dashcam, the ride-hailing firm said on Tuesday. This is expected to improve safety of drivers and comes against the backdrop of a 2021-22 safety report by Uber...
Copyright 2023-2025 - www.financetom.com All Rights Reserved